The Greens say the government should use unallocated discretionary funds set aside for COVID to begin work on a publicly-owned domestic vaccine manufacturer. If the government fails to act, the Greens plan to move in the Senate to demand action on domestic vaccine production when Parliament resumes.

The Australian Greens are calling for an urgent independent review into the serious and widespread problems with Australia’s vaccine rollout.

“The vaccine rollout for which both the Federal and State Governments have responsibility is having more than so called “teething problems” and these are having real-world consequences with the latest Covid-19 outbreaks spreading in Queensland and threatening in NSW,” Greens spokesperson on Health Senator Rachel Siewert said.

The Senate has today recognised that the climate crisis is the greatest threat to our health this century. 
 
“The fact is, the climate crisis is a health emergency”, Greens spokesperson on Health Senator Rachel Siewert said. 
 
“The Government acted on the science when it came to the COVID crisis and yet for decades they have refused to act on the science when it comes to the climate crisis. 
 

The Greens have said that Australia must support a World Trade Organization (WTO) proposal that would waive intellectual property provisions to allow Covid-19 vaccine production to be rolled out and made accessible and affordable to everyone in the global community.

The WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council is meeting this week, with the Covid-19 vaccine on the agenda.

Senator Mehreen Faruqi, Greens spokesperson for International Aid & Development, said:

The Australian Laywer’s Alliance "Doing More Harm Than Good: The need for a health-focused approach to drug use" report clearly shows that a national approach to harm minimisation is long overdue.  
 
"The legal and medical sectors have been saying for decades that treating drug use as a criminal matter, rather than a health issue does not work", Australian Greens Health spokesperson Senator Rachel Siewert said today. 
 

The Greens say that the Government will miss out on opportunities to expand and diversify Australia’s vaccine portfolio if they don’t invest in public capacity to produce mRNA vaccines

The Greens say quarantine facilities need to be established out of cities and that facilities must be publicly funded and run. 

“Our hotel quarantine system needs to be watertight. The UK, South Africa, Brazil variants are becoming the dominant variants in other parts of the world and we must keep these from getting out into our community”, Greens spokesperson on Health Senator Rachel Siewert said

The Greens welcome the news that AstraZeneca has been provisionally approved by the Therapeutic Goods Administration for use in Australia.
 
“However we cannot put all our eggs in one basket. It’s clear with differing rates of efficacy and with new Covid-19 strains developing that we must continue to expand and diversify Australia’s vaccine portfolio”, Australian Greens spokesperson on Health Senator Rachel Siewert said.
 

The Greens say the suspension of the AstraZeneca vaccine roll-out in South Africa shows the need for the government to establish a publicly-owned mRNA vaccine manufacturer in Australia.

Australia needs to be nimble and able to quickly adapt vaccines to ever-mutating strains of COVID, which would only be possible with a local, publicly owned facility that puts health, not profits, first.

Leader of the Australian Greens Adam Bandt MP said:

The Greens say that the Government must continue to expand and diversify Australia’s vaccine portfolio immediately in light of the varying rates of effectiveness of vaccines against new strains. 
 
“We cannot rely on AstraZeneca as our only contingency plan - we need to have a diverse portfolio to rapidly pivot to deal with new strains, including securing deals with Moderna and more Pfizer doses", Greens spokesperson on Health Senator Rachel Siewert said.